Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
"Swallowing these drugs every day, you get tired": a mixed-methods study to identify Barriers and facilitators to retention and HIV Viral Load suppression among the Adolescents living with HIV in TASO Mbale and TASO Soroti centers of excellence.
Oryokot B, Kazibwe A, Oluka AI, Kagimu D, Bakashaba B, Ssentongo S, Mafabi T, Odoi C, Kawuba A, Miya Y, Etukoit BM, Mugisha K, Namusoke-Magongo E. Oryokot B, et al. Among authors: miya y. Res Sq [Preprint]. 2024 Jan 17:rs.3.rs-3863602. doi: 10.21203/rs.3.rs-3863602/v1. Res Sq. 2024. PMID: 38313290 Free PMC article. Preprint.
Isoniazid preventive therapy completion between July-September 2019: A comparison across HIV differentiated service delivery models in Uganda.
Mugenyi L, Namuwenge PM, Ouma S, Bakashaba B, Nanfuka M, Zech J, Agaba C, Mijumbi Ojok A, Kaliba F, Bossa Kato J, Opito R, Miya Y, Katureebe C, Hirsch-Moverman Y. Mugenyi L, et al. Among authors: miya y. PLoS One. 2024 Jan 2;19(1):e0296239. doi: 10.1371/journal.pone.0296239. eCollection 2024. PLoS One. 2024. PMID: 38166009 Free PMC article.
Improving retention and HIV viral load suppression among adolescents living with HIV in TASO Soroti and TASO Mbale centers of excellence using Operation Triple Zero model: a before and after study protocol.
Oryokot B, Kazibwe A, Kagimu D, Oluka AI, Kato D, Miya Y, Etukoit MB, Namusoke-Magongo E. Oryokot B, et al. Among authors: miya y. Implement Sci Commun. 2023 Jun 12;4(1):65. doi: 10.1186/s43058-023-00449-9. Implement Sci Commun. 2023. PMID: 37308985 Free PMC article.
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection.
Khan K, Karim F, Ganga Y, Bernstein M, Jule Z, Reedoy K, Cele S, Lustig G, Amoako D, Wolter N, Samsunder N, Sivro A, San JE, Giandhari J, Tegally H, Pillay S, Naidoo Y, Mazibuko M, Miya Y, Ngcobo N, Manickchund N, Magula N, Karim QA, von Gottberg A, Abdool Karim SS, Hanekom W, Gosnell BI; COMMIT-KZN Team; Lessells RJ, de Oliveira T, Moosa MS, Sigal A. Khan K, et al. Among authors: miya y. Nat Commun. 2022 Oct 13;13(1):6057. doi: 10.1038/s41467-022-33371-0. Nat Commun. 2022. PMID: 36229444 Free PMC article. No abstract available.
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection.
Khan K, Karim F, Ganga Y, Bernstein M, Jule Z, Reedoy K, Cele S, Lustig G, Amoako D, Wolter N, Samsunder N, Sivro A, San JE, Giandhari J, Tegally H, Pillay S, Naidoo Y, Mazibuko M, Miya Y, Ngcobo N, Manickchund N, Magula N, Karim QA, von Gottberg A, Abdool Karim SS, Hanekom W, Gosnell BI; COMMIT-KZN Team; Lessells RJ, de Oliveira T, Moosa MS, Sigal A. Khan K, et al. Among authors: miya y. Nat Commun. 2022 Aug 10;13(1):4686. doi: 10.1038/s41467-022-32396-9. Nat Commun. 2022. PMID: 35948557 Free PMC article.
Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study.
Kazibwe A, Oryokot B, Mugenyi L, Kagimu D, Oluka AI, Kato D, Ouma S, Tayebwakushaba E, Odoi C, Kakumba K, Opito R, Mafabi CG, Ochwo M, Nkabala R, Tusiimire W, Kateeba Tusiime A, Alinga SB, Miya Y, Etukoit MB, Biraro IA, Kirenga B. Kazibwe A, et al. Among authors: miya y. PLoS One. 2022 May 16;17(5):e0266285. doi: 10.1371/journal.pone.0266285. eCollection 2022. PLoS One. 2022. PMID: 35576223 Free PMC article.
Omicron infection enhances Delta antibody immunity in vaccinated persons.
Khan K, Karim F, Cele S, Reedoy K, San JE, Lustig G, Tegally H, Rosenberg Y, Bernstein M, Jule Z, Ganga Y, Ngcobo N, Mazibuko M, Mthabela N, Mhlane Z, Mbatha N, Miya Y, Giandhari J, Ramphal Y, Naidoo T, Sivro A, Samsunder N, Kharsany ABM, Amoako D, Bhiman JN, Manickchund N, Abdool Karim Q, Magula N, Abdool Karim SS, Gray G, Hanekom W, von Gottberg A; COMMIT-KZN Team; Milo R, Gosnell BI, Lessells RJ, Moore PL, de Oliveira T, Moosa MS, Sigal A. Khan K, et al. Among authors: miya y. Nature. 2022 Jul;607(7918):356-359. doi: 10.1038/s41586-022-04830-x. Epub 2022 May 6. Nature. 2022. PMID: 35523247 Free PMC article.
Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant.
Khan K, Karim F, Cele S, San JE, Lustig G, Tegally H, Rosenberg Y, Bernstein M, Ganga Y, Jule Z, Reedoy K, Ngcobo N, Mazibuko M, Mthabela N, Mhlane Z, Mbatha N, Miya Y, Giandhari J, Ramphal Y, Naidoo T, Manickchund N, Magula N, Abdool Karim SS, Gray G, Hanekom W, von Gottberg A; COMMIT-KZN Team; Milo R, Gosnell BI, Lessells RJ, Moore PL, de Oliveira T, Moosa MS, Sigal A. Khan K, et al. Among authors: miya y. medRxiv [Preprint]. 2022 Jan 28:2021.12.27.21268439. doi: 10.1101/2021.12.27.21268439. medRxiv. 2022. PMID: 34981076 Free PMC article. Updated. Preprint.
Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV).
Khan K, Lustig G, Bernstein M, Archary D, Cele S, Karim F, Smith M, Ganga Y, Jule Z, Reedoy K, Miya Y, Mthabela N, Magula NP, Lessells R, de Oliveira T, Gosnell BI, Abdool Karim S, Garrett N, Hanekom W, Bekker LG, Gray G, Blackburn JM, Moosa MS, Sigal A; COMMIT-KZN Team. Khan K, et al. Among authors: miya y. Clin Infect Dis. 2022 Aug 24;75(1):e857-e864. doi: 10.1093/cid/ciab1008. Clin Infect Dis. 2022. PMID: 34893824 Free PMC article.
25 results